Microbot Med Inc (MBOT): Hedge Fund Ownership & Smart Money Signals (Q1 2026)

Q: Is it too late to buy Microbot Med Inc (MBOT) following the 2026 Q1 hedge fund 13F filings?

As of today, MBOT has moved nan% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), MBOT gained nan% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Microbot Med Inc (MBOT)

79 + Investors. Track Smart Money conviction in MBOT. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — MBOT

Based on 80 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 6 quarters in a row

last 6Q

For 6 consecutive quarters, more hedge funds added MBOT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

80 hedge funds hold MBOT right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +90% more funds vs a year ago

fund count last 6Q

+38 new funds entered over the past year (+90% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟢

More buyers than sellers — 64% buying

51 buying29 selling

Last quarter: 51 funds were net buyers (22 opened a brand new position + 29 added to an existing one). Only 29 were sellers (15 trimmed + 14 sold completely). A clear majority buying is a strong confirmation signal.

➡️

Steady new buyers — ~22 new funds per quarter

new funds entering per quarter

Funds opening this position for the first time: 15 → 28 → 21 → 22. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.

📌

Mixed — 25% long-term, 46% new

■ 25% conviction (2yr+) ■ 29% medium ■ 46% new

Of the 80 current holders: 20 (25%) held >2 years, 23 held 1–2 years, and 37 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

💰

Value +49% but shares only +24% — price-driven

Value

+48%

+23%

Last quarter: the total dollar value of institutional holdings rose +49%, but actual share count only changed +24%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.

➡️

Steady discovery — ~22 new funds/quarter

13 → 15 → 28 → 21 → 22 new funds/Q

New funds entering each quarter: 15 → 28 → 21 → 22. Consistent flow of new institutional buyers without clear acceleration or slowdown.

🌱

Early stage — 59% of holders entered in last year

■ 32% veterans ■ 9% 1-2yr ■ 59% new

Of 85 current holders: 50 (59%) entered in the past year, only 27 (32%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.

✅

Strong quality — 31% AUM from major funds

31% from top-100 AUM funds

22 of 78 holders rank in the top 100 by AUM, accounting for 31% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

5.0

out of 10

Moderate Exit Risk

Exit risk score 5.0/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	79	72	9.72%
13F Shares	15M	12M	23.5%
Total Value	$35M	$24M	48.4%
New Positions	21	21	-
Increased Positions	26	16	+10
Closed Positions	14	17	-3
Reduced Positions	15	17	-2
Total Calls	4	2	100.0%
Total Puts	3	3	-
PUT/CALL Ratio	0.75	1.5	Neutral

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

9.72%

13F Shares

15M

12M

23.5%

Total Value

$35M

$24M

48.4%

New Positions

Increased Positions

+10

Closed Positions

-3

Reduced Positions

-2

Total Calls

100.0%

Total Puts

PUT/CALL Ratio

0.75

1.5

Neutral

Institutional Holders (2026 Q1)

79 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in MBOT. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 MBOT holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	AlphaCentric Advisors LLC	0.48%	200,000	$482K
2	CTC Alternative Strategies, Ltd.	0.06%	11,718	$28K
3	Ancora Advisors LLC	0.02%	477,080	$1.1M
4	683 Capital Management, LLC	0.02%	170,000	$410K
5	Lazari Capital Management, INC.	0.02%	23,255	$56K
6	Caitong International Asset Management Co., Ltd	0.02%	35,862	$86K
7	Diametric Capital, LP	0.02%	24,382	$59K
8	Beacon Capital Management, LLC	0.01%	32,000	$77K
9	Catalyst Funds Management Pty Ltd	0.01%	21,900	$53K
10	Hilltop Holdings Inc.	0.01%	35,764	$86K
11	CIBC Bancorp USA Inc.	0.01%	1,870,000	$4.5M
12	DnB Asset Management AS	0.01%	677,498	$1.6M
13	Bridgeway Capital Management, LLC	0.00%	94,300	$227K
14	Quantbot Technologies LP	0.00%	26,588	$64K
15	Cornerstone Advisory, LLC	0.00%	10,000	$24K
16	OMERS ADMINISTRATION Corp	0.00%	85,500	$206K
17	Stifel Financial Corp	0.00%	573,075	$1.4M
18	Bfsg, LLC	0.00%	5,500	$13K
19	Marshall Wace, LLP	0.00%	481,045	$1.2M
20	Hudson Bay Capital Management LP	0.00%	121,082	$292K
21	Brevan Howard Capital Management LP	0.00%	35,931	$87K
22	Tower Research Capital LLC (TRC)	0.00%	8,547	$21K
23	Russell Investments Group, Ltd.	0.00%	198,622	$479K
24	Millennium Management LLC	0.00%	454,746	$1.1M
25	Vontobel Holding Ltd.	0.00%	48,088	$116K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Microbot Med Inc (MBOT)

What does the Smart Money Trend signal show for MBOT?

Buying streak — 6 quarters in a row: For 6 consecutive quarters, more hedge funds added MBOT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for MBOT?

More buyers than sellers — 64% buying: Last quarter: 51 funds were net buyers (22 opened a brand new position + 29 added to an existing one). Only 29 were sellers (15 trimmed + 14 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for MBOT holders?

Strong quality — 31% AUM from major funds: 22 of 78 holders rank in the top 100 by AUM, accounting for 31% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held MBOT?

Mixed — 25% long-term, 46% new: Of the 80 current holders: 20 (25%) held >2 years, 23 held 1–2 years, and 37 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Microbot Med Inc (MBOT) following the 2026 Q1 hedge fund 13F filings?

As of today, MBOT has moved nan% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), MBOT has gained nan% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Microbot Med Inc (MBOT)

Smart Money Signals — MBOT

Buying streak — 6 quarters in a row

At the ownership peak (100% of max)

Fast accumulation — +90% more funds vs a year ago

More buyers than sellers — 64% buying

Steady new buyers — ~22 new funds per quarter

Mixed — 25% long-term, 46% new

Value +49% but shares only +24% — price-driven

Steady discovery — ~22 new funds/quarter

Early stage — 59% of holders entered in last year

Strong quality — 31% AUM from major funds

Institutional Sentiment Summary — MBOT

Hedge Fund Ownership: MBOT

Market Analysis: MBOT

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: MBOT

Is It Too Late to Buy Microbot Med Inc (MBOT) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: MBOT

Statistics: MBOT

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q1)

Frequently Asked Questions — Microbot Med Inc (MBOT)

Welcome to 13Foresight!